Portable Ultrasound Devices Market Size is projected to witness exponential growth between 2022 and 2028 with the prevalence of chronic diseases and advancements in technology. The introduction of portable ultrasound devices across emerging areas, including critical care medicine, emergency medicine, anesthesiology, and musculoskeletal will foster the product demand across North America, Europe and Asia Pacific.
Portable ultrasound devices have become instrumental to enhance access to medical imaging and address the issue of maternal death and newborn deaths. These devices have become sought-after to reduce downtime and boost reliability. The machines have gained popularity for easy access to ultrasound when space is constrained. With a growing demand for ambulatory services, the industry outlook will be strong through 2028.
With respect to device type, handheld ultrasound devices will contribute a considerable share towards global market with a shifting trend towards remote patient monitoring. Some of the factors, such as affordability and use of these devices in ICUs to minimize the spread of COVID-19 will boost device adoption. With point-of-care ultrasound gaining traction, leading companies are expected to invest in portable devices.
In terms of end-use, hospitals will grow on account of the availability of skilled healthcare professionals. Physicians bank on portable devices to help in decision-making when treating patients in critical conditions. Point-of-care ultrasound devices are likely to be sought for increased efficiency and provide time-sensitive pharmaceutical treatments.
North America portable ultrasound devices market growth will be strong with the presence of leading manufacturers in the U.S. and Canada. Prominently, an increasing focus on the development of innovative products and the prevalence of infections and diseases have made North America a lucrative destination. Besides, leading companies are likely to explore opportunities in the demand for accurate medical imaging to treat cancer, for instance.
Global market share will rise with the presence of firms such as GE Healthcare, Canon Medical Systems Corporation, Fujifilm SonoSite, Inc., Philips Healthcare, FUJIFILM SonoSite, Siemens Healthcare, Clarius Mobile Health, Samsung Medical, Esaote SpA and Canon Medical Systems, among others. The competitive landscape indicates investments will be noticeable in organic and inorganic strategies, including mergers & acquisitions, product launches, R&D activities, and innovations.
In March 2021, GE Healthcare announced the launch of a wireless handheld ultrasound device for Europe and the U.S. customers. Meanwhile in June 2021, Samsung added smart healthcare centers at Government hospitals in India to contribute to COVID management. The healthcare center is equipped with digital ultrasound machines to boost diagnostic capacities and efficiencies.
Portable ultrasound solutions have become trendier for clinicians treating coronavirus patients owing to their ease of disinfection and imaging capabilities. Portable devices have exhibited prominence in imaging peripheral lung tissue affected by pneumonia. Hand-held and mobile ultrasound devices are poised to play an invaluable role in their efforts to fight the pandemic.
In May 2020, Philips received a green signal from the FDA for the use of its ultrasound to manage COVID-19-related cardiac and lung complications. Portable ultrasound devices have become sought-after to contain the spread of COVID-19 and will further gain traction from the use of telemedicine, remote monitoring and teleradiology.
With the broad portfolio, well-established players are predicted to boost investments in advancements in ultrasonography and mobile health. Adoption of state-of-the-art technologies, such as AI in imaging systems will also foster market outlook.
Market, by Device Type
Market, by Application
Market, by Emerging Areas
Market, by End-Use
The above information is provided for the following regions and countries: